A study of dose response and organ susceptibility of copper toxicity in a rat model

Journal of Trace Elements in Medicine and Biology

Volumn 29, Issue , 2015, Pages 269-274

  Kumar, Vijay ^a   Kalita, Jayantee ^a   Misra, U K ^a   Bora, H K ^b  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Brain; Copper; Kidney; Liver; Toxicity

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; COPPER SULFATE; NITROGEN; UREA; COPPER;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATTENTION; BEHAVIOR DISORDER; BILIRUBIN BLOOD LEVEL; BLOOD ANALYSIS; BODY WEIGHT; BRAIN LEVEL; CONTROLLED STUDY; DISEASE PREDISPOSITION; FALLING; GRIP STRENGTH; LATENT PERIOD; LIVER LEVEL; LIVER TOXICITY; LONG TERM EXPOSURE; MALE; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; RAT; ROTAROD TEST; UREA NITROGEN BLOOD LEVEL; Y-MAZE TEST; ANIMAL; ANIMAL BEHAVIOR; ANIMAL MODEL; ANTIBODY SPECIFICITY; COGNITION; DRUG EFFECTS; HAND STRENGTH; KIDNEY; LIVER; MAZE TEST; MOTOR ACTIVITY; PATHOLOGY; PATHOPHYSIOLOGY; REGRESSION ANALYSIS; WISTAR RAT;

RATTUS; RATTUS NORVEGICUS;

ANIMALS; BEHAVIOR, ANIMAL; BODY WEIGHT; COGNITION; COPPER; HAND STRENGTH; KIDNEY; LIVER; MALE; MAZE LEARNING; MODELS, ANIMAL; MOTOR ACTIVITY; ORGAN SPECIFICITY; RATS, WISTAR; REGRESSION ANALYSIS;

EID: 84919660997     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2014.06.004     Document Type: Article

References (34)

1. Linder M.C., Wooten L., Cerveza P., Cotton S., Shulze R., Lomeli N. Copper transport. Am J Clin Nutr 1998, 67:965S-971S.
2. Das S.K., Ray K. Wilson's disease: an update. Nat Clin Pract Neurol 2006, 2:482-493.
3. Ala A., Walker A.P., Ashkan K., Dooley J.S., Schilsky M.L. Wilson's disease. Lancet 2007, 369:397-408.
4. Chen D.B., Feng L., Lin X.P., Zhang W., Li F.R., Liang X.L., et al. Penicillamine increases free copper and enhances oxidative stress in the brain of toxic milk mice. PLoS One 2012, 7:e37709.
5. Choi B.S., Zheng W. Copper transport to the brain by the blood-brain barrier and blood-CSF barrier. Brain Res 2009, 1248:14-21.
6. Behari M., Pardasani V. Genetics of Wilsons disease. Parkinsonism Relat Disord 2010, 16:639-644.
7. Kalita J., Somarajan B.I., Misra U.K., Mittal B. R778L, H1069Q, and I1102T mutation study in neurologic Wilson disease. Neurol India 2010, 58:627-630.
8. Sinha S., Taly A.B. Withdrawal of penicillamine from zinc sulphate-penicillamine maintenance therapy in Wilson's disease: promising, safe and cheap. J Neurol Sci 2008, 264:129-132.
9. Theophilos M.B., Cox D.W., Mercer J.F. The toxic milk mouse is a murine model of Wilson disease. Hum Mol Genet 1996, 5:1619-1624.
10. Vonk W.I., Wijmenga C., van de Sluis B. Relevance of animal models for understanding mammalian copper homeostasis. Am J Clin Nutr 2008, 88:840S-845S.
11. Wu J., Forbes J.R., Chen H.S., Cox D.W. The LEC rat has a deletion in the copper transporting ATPase gene homologous to the Wilson disease gene. Nat Genet. 1994, 7:541-545.
12. Cisternas F.A., Tapia G., Arredondo M., Cartier-Ugarte D., Romanque P., Sierralta W.D., et al. Early histological and functional effects of chronic copper exposure in rat liver. Biometals 2005, 18:541-551.
13. Palm R., Wahlstrom G., Hallmans G. Age related changes in weight and the concentrations of zinc and copper in the brain of the adult rat. Lab Anim 1990, 24:240-245.
14. Pal A., Badyal R.K., Vasishta R.K., Attri S.V., Thapa B.R., Prasad R. Biochemical, histological, and memory impairment effects of chronic copper toxicity: a model for non-Wilsonian brain copper toxicosis in Wistar rat. Biol Trace Elem Res 2013, 153:257-268.
15. Boveris A., Musacco-Sebio R., Ferrarotti N., Saporito-Magrina C., Tori H., Massot F., et al. The acute toxicity of iron and copper: biomolecule oxidation and oxidative damage in rat liver. J Inorg Biochem 2012, 116:63-69.
16. Ozcelik D., Uzun H. Copper intoxication; antioxidant defenses and oxidative damage in rat brain. Biol Trace Elem Res 2009, 127:45-52.
17. Fujiwara N., Iso H., Kitanaka N., Kitanaka J., Eguchi H., Ookawara T., et al. Effects of copper metabolism on neurological functions in Wistar and Wilson's disease model rats. Biochem Biophys Res Commun 2006, 349:1079-1086.
18. Howell J.S. Histochemical demonstration of copper in copper-fed rats and in hepatolenticular degeneration. J Pathol Bacteriol 1959, 77:473-484.
19. Toyokuni S., Okada S., Hamazaki S., Fujioka M., Li J.L., Midorikawa O. Cirrhosis of the liver induced by cupric nitrilotriacetate in Wistar rats. An experimental model of copper toxicosis. Am J Pathol 1989, 134:1263-1274.
20. Waggoner D.J., Bartnikas T.B., Gitlin J.D. The role of copper in neurodegenerative disease. Neurobiol Dis 1999, 6:221-230.
21. Narasaki M. Laboratory and histological similarities between Wilson's disease and rats with copper toxicity. Acta Med Okayama 1980, 34:81-90.
22. Pal A., Vasishta R., Prasad R. Hepatic and hippocampus iron status is not altered in response to increased serum ceruloplasmin and serum "free" copper in Wistar rat model for non-Wilsonian brain copper toxicosis. Biol Trace Elem Res 2013, 154:403-411.
23. Singh I., Sagare A.P., Coma M., Perlmutter D., Gelein R., Bell R.D., et al. Low levels of copper disrupt brain amyloid-beta homeostasis by altering its production and clearance. Proc Natl Acad Sci U S A 2013, 110:14771-14776.
24. Stuart M.A., Johnson P.E. Copper absorption and copper balance during consecutive periods for rats fed varying levels of dietary copper. J Nutr 1986, 116:1028-1036.
25. Musacco-Sebio R., Ferrarotti N., Saporito-Magrina C., Semprine J., Fuda J., Torti H., et al. Oxidative damage to rat brain in iron and copper overloads. Metallomics 2014.
26. Leiva J., Palestini M., Infante C., Goldschmidt A., Motles E. Copper suppresses hippocampus LTP in the rat, but does not alter learning or memory in the morris water maze. Brain Res 2009, 1256:69-75.
27. Przybylkowski A., Gromadzka G., Wawer A., Bulska E., Jablonka-Salach K., Grygorowicz T., et al. Neurochemical and behavioral characteristics of toxic milk mice: an animal model of Wilson's disease. Neurochem Res 2013, 38:2037-2045.
28. Diaz-Veliz G., Paris I., Mora S., Raisman-Vozari R., Segura-Aguilar J. Copper neurotoxicity in rat substantia nigra and striatum is dependent on DT-diaphorase inhibition. Chem Res Toxicol 2008, 21:1180-1185.
29. Hosseini M.J., Shaki F., Ghazi-Khansari M., Pourahmad J. Toxicity of copper on isolated liver mitochondria: impairment at complexes I, II, and IV leads to increased ROS production. Cell Biochem Biophys 2014.
30. Das M., Misra U.K., Kalita J. A study of clinical, MRI and multimodality evoked potentials in neurologic Wilson disease. Eur J Neurol 2007, 14:498-504.
31. Kalita J., Kumar V., Chandra S., Kumar B., Misra U.K. Worsening of Wilson disease following penicillamine therapy. Eur Neurol 2014, 71:126-131.
32. Kasai N., Osanai T., Miyoshi I., Kamimura E., Yoshida M.C., Dempo K. Clinico-pathological studies of LEC rats with hereditary hepatitis and hepatoma in the acute phase of hepatitis. Lab Anim Sci 1990, 40:502-505.
33. Rauch H., Wells A.J. The toxic milk mutation, tx, which results in a condition resembling Wilson disease in humans, is linked to mouse chromosome 8. Genomics 1995, 29:551-552.
34. Desai V., Kaler S.G. Role of copper in human neurological disorders. Am J Clin Nutr 2008, 88:855S-858S.